RIGEL PHARMACEUTICALS INC

RIGL

—

Advanced chart & tools →

RIGEL PHARMACEUTICALS INCRIGL

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$19.48

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$294.28M

Net income

$367.02M

Net margin

124.7%

Gross margin

5.9%

Dividends & financials

RIGEL PHARMACEUTICALS INC (RIGL) reported revenue of $294.28M and net income of $367.02M, or $19.48 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.